The temporal relationship between depressive symptoms and dementia: A community-based prospective study

Archives of General Psychiatry

Volumn 56, Issue 3, 1999, Pages 261-266

  Chen, Peijun ^a   Ganguli, Mary ^a,b   Mulsant, Benoit H ^b   DeKosky, Steven T ^b  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; SYMPTOMATOLOGY;

EID: 0033019420     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.56.3.261     Document Type: Article

References (53)

1. Katzman R. The prevalence and malignancy of Alzheimer's disease: a major killer [editorial]. Arch Neurol. 1976;33:217-218.
2. Blazer DG, Hughes DC, George LK. The epidemiology of depression in an elderly community population. Gerontologist. 1987;27:281-287.
3. Alexopoulos GS, Meyers BS, Young RC, Mattis S, Kakuma T. The course of geriatric depression with "reversible dementia": a controlled study. Am J Psychiatry. 1993;150:1693-1699.
4. Emery VO, Oxman TE. Update on the dementia spectrum of depression. Am J Psychiatry. 1992;149:305-317.
5. Rovner BW, Broadhead J, Spencer M, Carson K, Folstein MF. Depression and Alzheimer's disease. Am J Psychiatry. 1989;146:350-353.
6. Dufouil C, Fuhrer R, Dartigues JF, Alperovitch A. Longitudinal analysis of the association between depressive symptomatology and cognitive deterioration. Am J Epidemiol. 1996;144:634-641.
7. Lichtenberg PA, Ross T, Millis SR, Manning CA. The relationship between depression and cognition in older adults: a cross-validation study. J Gerontol B Psychol Sci Soc Sci. 1995;50:P25-P32.
8. Lobo A, Saz P, Marcos G, Dia JL, De-la-Camara C. The prevalence of dementia and depression in the elderly community in a southern European population: the Zaragoza Study. Arch Gen Psychiatry. 1995;52:497-506.
9. Mangione CM, Seddon JM, Cook EF, Krug JH Jr, Sahagian CR, Campion EW, Glynn RJ. Correlates of cognitive function scores in elderly outpatients. J Am Geriatr Soc. 1993;41:491-497.
10. Burns A, Jacoby R, Levy H. Psychiatric phenomena in Alzheimer's disease, I and III: disorders of thought content. Br J Psychiatry. 1990;157:72-76, 92-94.
11. Andersen G, Vestergaard K, Riis JØ, Ingeman-Nielsen M. Dementia of depression or depression of dementia in stroke? Acts Psychiatr Scand. 1996;94:272-278.
12. Broe GA, Henderson AS, Creasey H, McCusker E, Korten AE, Jorm AF, Longley W, Anthony JC. A case-control study of Alzheimer's disease in Australia. Neurology. 1990;40:1698-1707.
13. Merriam AE, Aronson MK, Gaston P, Wey SL, Katz I. The psychiatric symptoms of Alzheimer's disease. J Am Geriatr Soc. 1988;36:7-12.
14. Reifler BV, Larson E, Teri L, Poulsen M. Dementia of the Alzheimer's type and depression. J Am Geriatr Soc. 1986;34:855-859.
15. Cummings JL, Ross W, Absher J, Gornbein J, Hadjiaghai L. Depressive symptoms in Alzheimer disease. Alzheimer Dis Assoc Disord. 1995;9:87-93.
16. Speck CE, Kukull WA, Brenner DE, Bowen JD, McCormick WC, Teri L, Pfanschmidt ML, Thompson JD, Larson EB. History of depression as a risk factor for Alzheimer's disease. Epidemiology. 1995;6:366-369.
17. Knesevich JW, Martin RL, Berg L, Danziger W. Preliminary report on affective symptoms in the early stages of senile dementia of the Alzheimer type. Am J Psychiatry. 1983;140:233-235.
18. Henderson AS, Korten AE, Jacomb PA, Mackinnon AJ, Jorm AF, Christensen H, Rodgers B. The course of depression in the elderly: a longitudinal community-based study in Australia. Psychol Med. 1997;27:119-129.
19. Jorm AF, van Duijn CM, Chandra V, Fratiglioni L, Graves AB, Heyman A, Kokmen E, Kondo K, Mortimer JA, Rocca WA, Shalat SL, Soininen H, Hofman A, for the EURODEM Risk Factors Research Group. Psychiatric history and related exposures as risk factors for Alzheimer's disease. Int J Epidemiol. 1991;20(suppl 2): S43-S47.
20. Buntinx F, Kester A, Bergers J, Knottnerus JA. Is depression in elderly people followed by dementia? Age Ageing. 1996;25:231-233.
21. Devanand DP, Sano M, Tang MX, Taylor S, Gurland BJ, Wilder D, Stern Y, Mayeux R. Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry. 1996;53:175-182.
22. Ganguli M, Belle S, Ratcliff G, Seaberg E, Huff FJ, von der Porten K, Kuller LH. Sensitivity and specificity for dementia of population-based criteria for cognitive impairment: the MoVIES project. J Gerontol. 1993;48:M152-M161.
23. Ganguli M, Gilby J, Seaberg E, Belle S. Depressive symptoms and associated factors in a rural elderly population: the MoVIES project. Am J Geriatr Psychiatoy. 1995;3:144-160.
24. Radlotf LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measure. 1977;1:385-401.
25. Ganguli M, Ratcliff G, Belle S, Huff FJ, Kancel MJ, Fischer L, Kuller LH. Effects of age, gender, and education on cognitive tests in an elderly rural community sample: norms from the Monongahela Valley Independent Elders Survey (MoVIES). Neuroepidemiology. 1991;10:42-52.
26. Ganguli M, Ratcliff G, DeKosky S. Cognitive test scores in community-based rural elderly with and without dementia. Aging Mental Health. 1997;1:176-180.
27. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), I: clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989;39:1159-1165.
28. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method of grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12:189-198.
29. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC: American Psychiatric Association: 1987.
30. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
31. SAS/STAT User's Guide, Version 6.4th ed. Cary, NC: SAS Institute Inc; 1989.
32. Cox DR. Regression models and life-tables (with discussion). J R Stat Soc Ser B. 1972;34:187-220.
33. Rosner B. Fundamentals of Biostatistics. 4th ed. Harrisonburg, Va: Duxbury Press; 1995:404-413.
34. Copeland JRM, Davidson IA, Dewey ME, Gilmore C, Larkin BA, McWilliam C, Saunders PA, Scott A, Sharma V, Sullivan C. Alzheimer's disease, other dementias, depression and pseudodementia: prevalence, incidence and three-year outcome in Liverpool. Br J Psychiatry. 1992;161:230-239.
35. Kral VA. The relationship between senile dementia (Alzheimer type) and depression. Can J Psychiatry. 1983;28:304-306.
36. Zubenko GS, Moossy J. Major depression in primary dementia: clinical and neuropathologic correlates. Arch Neurol. 1988;45:1182-1186.
37. Forstl H, Levy R, Bums A, Luthert P, Cairns N. Disproportionate loss of noradrenergic and cholinergic neurons as cause of depression in Alzheimer's disease: a hypothesis. Pharmacopsychiatry. 1994;27:11-15.
38. Forstl H, Bums A, Luthert P, Cairns N, Lantos P, Levy R. Clinical and neuropathological correlates of depression in Alzheimer's disease. Psychol Med. 1992; 22:877-884.
39. Zweig RM, Cardillo JE, Cohen M, Giere S, Hedreen JC. The locus ceruleus and dementia in Parkinson's disease. Neurology. 1993;43:986-991.
40. Sapolsky RM, Krey LC, McEwen B. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev. 1986;7:284-301.
41. O'Brien JT, Ames D, Schweizer I, Colman P, Desmond P, Tress B. Clinical and magnetic resonance imaging correlates of hypothalamic-pituitary-adrenal axis function in depression and Alzheimer's disease. Br J Psychiatry. 1996;168:679-687.
42. Jacobson L, Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev. 1991;12:118-134.
43. Kaye JA, Swihart T, Howieson D, Dame A, Moore MM, Kamos T, Camicioli R, Ball M, Oken B, Sexton G. Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurology. 1997;48:1297-1304.
44. Reid W, Broe G, Creasey H, Grayson D, McCusker E, Bennett H, Longley W, Sulway MR. Age at onset and pattern of neuropsychological impairment in mild early-stage Alzheimer's disease. Arch Neurol. 1996;53:1056-1061.
45. Hyman BT, Van Hoesen GW, Damasio AR. Memory-related neural systems in Alzheimer's disease: an anatomic study. Neurology. 1990;40:1721-1730.
46. Checkley S. Neuroendocrine mechanisms and the precipitation of depression by life events. Br J Psychiatry Suppl. 1992;No. 15:7-17.
47. Dinan TG. Glucocorticoids and the genesis of depressive illness. Br J Psychiatry. 1994;164:365-371.
48. Heuser I. The hypothalamic-pituitary-adrenal system in depression. Pharmacopsychiatry. 1998;31:10-13.
49. Cummings JL, Cyrus PA, Bieber F, Mas J, Orazem J, Gulanski B. Metrifonate treatment of the cognitive deficits of Alzheimer's disease: Metrifonate Study Group [published correction appears in Neurology. 1998;51:332]. Neurology. 1998;50:1214-1221.
50. Cummings JL. Metrifonate: overview of safety and efficacy. Pharmacotherapy. 1998;18(pt2):43-46; discussion, 79-82.
51. Kaufer O, Cummings JL, Christine D, Differential neuropsychiatric symptom responses to tacrine in Alzheimer's disease: relationship to dementia severity. J Neuropsychiatry Clin Neurosci. 1998;10:55-63.
52. Kaufer D. Beyond the cholinergic hypothesis: the effect of metrifonate and other cholinesterase inhibitors on neuropsychiatric symptoms in Alzheimer's disease. Dementia Geriatr Cogn Disord. 1998;9(suppl 2):8-14.
53. Kaufer DI, Cummings JL, Christine D. Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study. J Geriatr Psychiatry Neurol. 1996;9:1-6.